Innisfil Fire and Rescue Services has integrated neffy, an epinephrine nasal spray, into its emergency medical kits, making it the first fire department in Canada to carry the needle-free device for severe allergic reactions, according to local news reports. Administered to treat anaphylaxis—a rapid, life-threatening allergic reaction triggered by food, insect venom, or medication—the spray provides emergency responders with a fast-acting alternative to traditional auto-injectors like the EpiPen, according to statements from Fire Chief Brent Thomas and ALK Canada marketing director Francesca Passudetti.
Why Innisfil Fire Added Epinephrine Nasal Spray to Medical Kits
When emergency crews respond to calls for anaphylaxis, seconds matter, according to Fire Chief Brent Thomas. The department added the needle-free device across three response vehicles and three stations following approvals from Health Canada. While being the first department in the country to adopt the nasal spray brought national attention, Thomas noted that the primary motivation was patient care. “Our goal was simple: to provide the best possible care for our community, period,” Thomas said, according to source reports.

The rollout follows comprehensive training for 40 career firefighters and 20 volunteer firefighters, ensuring crews can deploy the spray quickly during high-stress medical calls. According to the town’s fire service medical director, Dr. Ian Young, the addition of intranasal epinephrine serves as an evidence-based option designed to reduce hesitation among responders and improve patient acceptance of life-saving treatment.
Overcoming Needle Hesitation During Anaphylatic Emergencies
Needle phobia and hesitation during high-stress situations can delay critical medical interventions. According to Francesca Passudetti, director of marketing for ALK Canada, having an alternative to needle-style auto-injectors helps alleviate anxiety for patients and families. “When a severe allergic reaction strikes, every second counts. This allows a sense of security for families living with severe allergies,” Passudetti said.
Medical experts emphasize that epinephrine remains the cornerstone of early management for anaphylaxis. By removing barriers related to needle administration, fire services aim to speed up delivery times when patients face acute exposure to allergens.
Pro Tip for Residents: According to Innisfil Fire and Rescue Services, the neffy units carried on emergency vehicles are designated for rapid response and do not replace personal prescriptions. Residents with severe allergies must continue to carry their own prescribed epinephrine devices at all times.
Public Perception and Community Safety Gaps
The adoption of the nasal spray highlights ongoing efforts to bridge gaps in emergency medical response. According to data from a Food Allergy Canada survey cited by the Town of Innisfil, 91 percent of Canadians believe paramedics carry epinephrine devices on scene, but confidence drops to 64 percent when considering whether firefighters are equipped to handle the first critical minutes of an allergic reaction.

By equipping all response vehicles with both traditional auto-injectors and the new nasal spray, Innisfil aims to close that confidence gap and ensure immediate intervention when severe reactions occur.
Frequently Asked Questions
What is neffy?
Neffy is a needle-free epinephrine nasal spray designed to treat severe, life-threatening allergic reactions known as anaphylaxis, providing rapid absorption through the nasal mucosa.
Are Innisfil firefighters still carrying EpiPens?
Yes. According to Fire Chief Brent Thomas, the nasal spray serves as an alternative option, and traditional auto-injectors remain part of the department’s emergency medical kits.
Does this replace personal epinephrine prescriptions?
No. The units carried by Innisfil Fire and Rescue Services are intended exclusively for emergency response. Residents with severe allergies must maintain their own personal prescriptions.
Did the product require regulatory approval in Canada?
Yes. According to ALK Canada, the product cleared several regulatory hurdles, including official approvals from Health Canada, before deployment.
Stay Updated on Local Emergency Services
Have thoughts on this new emergency medical rollout? Share your comments below, subscribe to our newsletter for community updates, or explore more local health and safety news on our site.
Related reading